Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice

FEBS Letters

Volumn 584, Issue 15, 2010, Pages 3359-3365

  Li, Bin ^a   Wanka, Lukas ^a   Blanchard, Julie ^a   Liu, Fei ^a   Chohan, Muhammad Omar ^a   Iqbal, Khalid ^a   Grundke Iqbal, Inge ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Adamantane derivative; Alzheimer disease; Ciliary neurotrophic factor; Cognition; Neuronal plasticity; Pharmacology; Synaptogenesis

Indexed keywords

ADAMANTANE DERIVATIVE; NEUROTROPHIC FACTOR; P21; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENTATE GYRUS; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEARNING; MEMORY; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SHORT TERM MEMORY; SPATIAL MEMORY;

ADAMANTANE; AGING; ANIMALS; BEHAVIOR, ANIMAL; COGNITION; DENTATE GYRUS; LEUKEMIA INHIBITORY FACTOR; MEMORY; MICE; NERVE GROWTH FACTORS; NEUROGENESIS; NEURONAL PLASTICITY; PEPTIDES; RECOGNITION (PSYCHOLOGY); SIGNAL TRANSDUCTION; SYNAPSES;

MUS;

EID: 77955277731     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.06.025     Document Type: Article

References (45)

1. Iqbal K., Grundke-Iqbal I. Developing pharmacological therapies for Alzheimer disease. Cell. Mol. Life Sci. 2007, 64:2234-2244.
2. Ruther E., Ritter R., Apecechea M., Freytag S., Gmeinbauer R., Windisch M. Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy. J. Neural. Transm. 2000, 107:815-829.
3. Alvarez X.A., et al. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Eur. J. Neurol. 2006, 13:43-54.
4. Mallory M., Honer W., Hsu L., Johnson R., Rockenstein E., Masliah E. In vitro synaptotrophic effects of Cerebrolysin in NT2N cells. Acta Neuropathol. 1999, 97:437-446.
5. Chen H., Tung Y.C., Li B., Iqbal K., Grundke-Iqbal I. Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis. Neurobiol. Aging 2007, 28:1148-1162.
6. Francis-Turner L., Valouskova V. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Neurosci. Lett. 1996, 202:193-196.
7. Masliah E., Armasolo F., Veinbergs I., Mallory M., Samuel W. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol. Biochem. Behav. 1999, 62:239-245.
8. Tatebayashi Y., Lee M.H., Li L., Iqbal K., Grundke-Iqbal I. The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. Acta Neuropathol. (Berl) 2003, 105:225-232.
9. Rockenstein E., Mante M., Adame A., Crews L., Moessler H., Masliah E. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease. Acta Neuropathol. 2007, 113:265-275.
10. Chohan, M.O., Li, B., Blanchard, J., Tung, Y.C., Heaney, A.T., Rabe, A., Iqbal, K. and Grundke-Iqbal, I. (2009). Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide. Neurobiol. Aging, Epub ahead of print, Sept. 2009.
11. Blanchard, J., Chohan, M.O., Li, B., Liu, F., Iqbal, K. and Grundke-Iqbal, I. (2010). Beneficial effect of a CNTF tetrapeptide on adult hippocampal neurogenesis, neuronal plasticity and spatial memory in mice. J. Alzheimer's Dis., in press.
12. SG A.C.T. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology 1996, 46:1244-1249.
13. Windisch M., Gschanes A., Hutter-Paier B. Neurotrophic activities and therapeutic experience with a brain derived peptide preparation. J. Neural. Transm. Suppl. 1998, 53:289-298.
14. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 1999, 2:260-265.
15. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376.
16. Snyder J.S., Hong N.S., McDonald R.J., Wojtowicz J.M. A role for adult neurogenesis in spatial long-term memory. Neuroscience 2005, 130:843-852.
17. Schindowski K., Bretteville A., Leroy K., Begard S., Brion J.P., Hamdane M., Buee L. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol. 2006, 169:599-616.
18. Price R.D., Milne S.A., Sharkey J., Matsuoka N. Advances in small molecules promoting neurotrophic function. Pharmacol. Ther. 2007, 115:292-306.
19. Kitagawa K., Mizobuchi N., Hama T., Hibi T., Konishi R., Futaki S. Synthesis and antinociceptive activity of [D-Ala2]Leu-enkephalin derivatives conjugated with the adamantane moiety. Chem. Pharm. Bull. (Tokyo) 1997, 45:1782-1787.
20. Tsuzuki N., Hama T., Hibi T., Konishi R., Futaki S., Kitagawa K. Adamantane as a brain-directed drug carrier for poorly absorbed drug: antinociceptive effects of [D-Ala2]Leu-enkephalin derivatives conjugated with the 1-adamantane moiety. Biochem. Pharmacol. 1991, 41:R5-R8.
21. Frackenpohl J., Arvidsson P.I., Schreiber J.V., Seebach D. The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. ChemBioChem 2001, 2:445-455.
22. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
23. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
24. Masliah E., Honer W.G., Mallory M., Voigt M., Kushner P., Hansen L., Terry R. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol. 1994, 87:135-142.
25. Sze C.I., Bi H., Kleinschmidt-DeMasters B.K., Filley C.M., Martin L.J. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J. Neurol. Sci. 2000, 175:81-90.
26. Hsia A.Y., et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 1999, 96:3228-3233.
27. Lanz T.A., Carter D.B., Merchant K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 2003, 13:246-253.
28. Mitchell J.B., Laiacona J. The medial frontal cortex and temporal memory: tests using spontaneous exploratory behaviour in the rat. Behav. Brain Res. 1998, 97:107-113.
29. Ennaceur A., Aggleton J.P. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav. Brain Res. 1997, 88:181-193.
30. Ennaceur A., Neave N., Aggleton J.P. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp. Brain Res. 1997, 113:509-519.
31. Clark R.E., Zola S.M., Squire L.R. Impaired recognition memory in rats after damage to the hippocampus. J. Neurosci. 2000, 20:8853-8860.
32. Ennaceur, A. (2010). One-trial objects recognition in rats and mice: methodological and theoritical issues. Behav. Brain Res., in press.
33. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
34. Riedel G., et al. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat. Neurosci. 1999, 2:898-905.
35. Jahn R., Schiebler W., Ouimet C., Greengard P. A 38000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA 1985, 82:4137-4141.
36. Janz R., Sudhof T.C., Hammer R.E., Unni V., Siegelbaum S.A., Bolshakov V.Y. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 1999, 24:687-700.
37. Arthur C.P., Stowell M.H. Structure of synaptophysin: a hexameric MARVEL-domain channel protein. Structure 2007, 15:707-714.
38. Greengard P., Valtorta F., Czernik A.J., Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259:780-785.
39. Aimone J.B., Wiles J., Gage F.H. Potential role for adult neurogenesis in the encoding of time in new memories. Nat. Neurosci. 2006, 9:723-727.
40. Kee N., Teixeira C.M., Wang A.H., Frankland P.W. Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat. Neurosci. 2007, 10:355-362.
41. Li B., Yamamori H., Tatebayashi Y., Shafit-Zagardo B., Tanimukai H., Chen S., Iqbal K., Grundke-Iqbal I. Failure of neuronal maturation in Alzheimer disease dentate gyrus. J. Neuropathol. Exp. Neurol. 2008, 67:78-84.
42. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2004, 101:343-347.
43. Shimazaki T., Shingo T., Weiss S. The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J. Neurosci. 2001, 21:7642-7653.
44. Bonaguidi M.A., McGuire T., Hu M., Kan L., Samanta J., Kessler J.A. LIF and BMP signaling generate separate and discrete types of GFAP-expressing cells. Development 2005, 132:5503-5514.
45. Bauer S., Patterson P.H. Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain. J. Neurosci. 2006, 26:12089-12099.